Drug Insights

A Complete Guide to Searching Misoprostol on Synapse

19 March 2024
2 min read

Misoprostol is a small molecule drug that exerts its pharmacological effects through the activation of EP2 receptors in the body. This agonist drug binds to the EP2 receptors, leading to various effects, such as decreasing stomach acid secretion, promoting cervical ripening, and inducing labor. Misoprostol was approved for medical use in June 1984 and has been widely employed for several therapeutic purposes, including preventing and treating gastric ulcers associated with NSAIDs use, as well as in inducing labor or termination of pregnancy. Pfizer AS developed the drug, which is only available by prescription and considered a safe and effective medication. Despite its benefits, Misoprostol can cause potential side effects, including uterine contractions, gastrointestinal discomfort, and rare cases of uterine rupture. Therefore, Misoprostol should be used with caution and under medical supervision. Click on the image below to begin the exploration journey of Misoprostol through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Zai Lab will showcase research on its innovative ADC therapy, ZL-1310, for combating solid cancers
Latest Hotspot
3 min read
Zai Lab will showcase research on its innovative ADC therapy, ZL-1310, for combating solid cancers
19 March 2024
Zai Lab Limited plans to present early data highlighting the potential therapeutic effects of its global antibody-drug conjugate project, ZL-1310.
Read →
What does semaglutide do?
"What" Series
2 min read
What does semaglutide do?
19 March 2024
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that plays a multifaceted role in managing type 2 diabetes and promoting weight loss.
Read →
FDA Approves Mirum's LIVMARLI for Itchy Skin in Liver Disorder Patients
Latest Hotspot
3 min read
FDA Approves Mirum's LIVMARLI for Itchy Skin in Liver Disorder Patients
19 March 2024
FDA Grants Authorization for Mirum Pharmaceuticals' Drug LIVMARLI to Treat Itchy Skin Caused by Bile Buildup in Individuals with Advanced Hereditary Liver Disorder.
Read →
Maximize Your Synapse Use: Your Guide to Searching Atendol
Drug Insights
2 min read
Maximize Your Synapse Use: Your Guide to Searching Atendol
19 March 2024
Atendol, a small molecule drug, falls under the ambit of the β1-adrenergic receptor antagonists class.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.